By ordering diagnostic procedures to determine the next course of treatment, Urologists play an important role in the management and care of the prostate cancer patient. This diagnosis and management can vary based on the availability of the latest technology. PSMA -11 PET-CT can accurately detect prostate cancer spread and offers improved patient outcomes.

This CME accredited Expert Forum Webinar features a panel of experts in their respective areas of medical imaging including; Nuclear Medicine, Urology, and Oncology. Each will share their experiences of the clinical utility of PSMA-11 PET/CT and its impact on patient management; delivering a clear understanding of the benefits of PSMA-11 imaging. Following the webinar, attendees are afforded the opportunity to correspond with the panel members through email to address questions and discuss specific patient needs.

Jeremie Calais, MD, MSc Clinical Research Director; Assistant Professor Ahmanson Translational Theranostics Division UCLA

Jeffrey Karnes, MD Chair, Division of Community Urology Department of Urology Mayo Clinic

Oliver Sartor, MD Laborde Professor of Cancer Research Medical Director, Tulane Cancer Center Tulane University School of Medicine